Joseph Gunnar Wentling

Mr. Joseph Gunnar Wentling

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2025 in Current Pain and Headache Reports
Verified
Journal Article
Closed access
PDF file
SAShahab Ahmadzadeh
Shahab Ahmadzadeh
JWJoseph Gunnar Wentling
Joseph Gunnar Wentling
BFBennett Ford
Bennett Ford
JYJade Alexandra Tom Yew
Jade Alexandra Tom Yew
SBSonnah A. Barrie
Sonnah A. Barrie
Alan David KayeAlan David Kaye
Alan David Kaye

20 May 2025 in PM&R
Verified
Journal Article
Closed access
JWJoseph Gunnar Wentling
Joseph Gunnar Wentling
MFMichael Forte
Michael Forte
TCTaylor A. Colon
Taylor A. Colon
EREvan Reuter
Evan Reuter

28 May 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
Alan David KayeAlan David Kaye
Alan David Kaye
BEBenjamin Esneault
Benjamin Esneault
SDShreya Deshpande
Shreya Deshpande
JWJoseph Gunnar Wentling
Joseph Gunnar Wentling
SAShahab Ahmadzadeh
Shahab Ahmadzadeh
SSSahar Shekoohi
Sahar Shekoohi
Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures, affecting millions worldwide. While anti-seizure medications serve as first-line treatment, approximately one-third of patients develop drug-resistant epilepsy (DRE), necessitating alternative interventions. Deep brain stimulation (DBS) has emerged as a promising therapy for DRE, particularly for patients who are ineligible for resective surgery. DBS involves stereotactic implantation of electrodes into target brain regions, such as the anterior nucleus of the thalamus (ANT), centromedian nucleus (CMT), and hippocampus (HC), to modulate aberrant neural activity and to reduce seizure frequency. Anesthesia plays a critical role in DBS implantation, influencing both patient safety and procedural success. The choice of anesthetic technique must balance patient comfort with the preservation of neurophysiological signals used for intraoperative electrode localization. A well-chosen anesthetic strategy can enhance the efficacy of electrode placement by minimizing patient movement and preserving critical neurophysiological signals for real-time monitoring. This precise targeting enhances safety via a reduction in perioperative risks and an improvement in long-term seizure control. Anesthetic considerations in epilepsy patients differ from those in movement disorders due to variations in their nuclei targets during DBS. Despite the increasing use of DBS for epilepsy following its FDA approval in 2018, research on anesthetic effects specific to this population remains limited. This narrative review, therefore, examines anesthetic approaches, pharmacological implications, potential complications, and evolving methods for DBS implantation in epilepsy patients, highlighting new insights and unique considerations in this population. Understanding these factors is essential for optimizing surgical outcomes and improving the safety and efficacy of DBS in epilepsy treatment.

2 July 2026
Verified
Book Chapter
Closed access
PDF file
MLMary Kathleen Luetkemeier
Mary Kathleen Luetkemeier
JWJoseph Gunnar Wentling
Joseph Gunnar Wentling
SAShahab Ahmadzadeh
Shahab Ahmadzadeh
SSSahar Shekoohi
Sahar Shekoohi
Alan David KayeAlan David Kaye
Alan David Kaye

2 July 2026
Verified
Book Chapter
Closed access
PDF file
JWJoseph Gunnar Wentling
Joseph Gunnar Wentling
MWMadison Claire Wolf
Madison Claire Wolf
ACAnnabelle B. Clark
Annabelle B. Clark
SSSahar Shekoohi
Sahar Shekoohi
SAShahab Ahmadzadeh
Shahab Ahmadzadeh
Alan David KayeAlan David Kaye
Alan David Kaye

2 July 2026
Verified
Book Chapter
Closed access
PDF file
TBTrevor Blackstock
Trevor Blackstock
JWJoseph Gunnar Wentling
Joseph Gunnar Wentling
MDMary O'Dell Duplechin
Mary O'Dell Duplechin
SSSahar Shekoohi
Sahar Shekoohi
Alan David KayeAlan David Kaye
Alan David Kaye